ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

12 links0 made here, not in the record11 judgments1 judge (the rules as one: Rule based)1 record change seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04739813Venetoclax, Ibrutinib,Prednisone, Obinutuzumab,and Revlimid in CombinationWith Polatuzumab (ViPOR-P)in Relapsed/RefractoryB-cell LymphomaNational Cancer Institute (NCIPhase 1 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Version of 2026-11-12CONDITIONSLymphomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Lymphoma, Non-HodgkinThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionLymphoma, Large B-Cell, Dif…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Burkitt LymphomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSObinutuzumabIntervention entry›As of now · Rule based · BackgroundBackgroundPrednisoneIntervention entry›As of now · Rule based · BackgroundBackgroundLenalidomideEntry “Revlimid”, read by our name ru…›As of now · Rule based · BackgroundBackgroundPolatuzumabIntervention entry›As of now · Rule based · TestedAs of now · Rule based · TestedTestedIbrutinibIntervention entry›As of now · Rule based · BackgroundBackgroundVenetoclaxIntervention entry›As of now · Rule based · BackgroundAs of now · Rule based · BackgroundBackgroundAcetaminophenIntervention entry›As of now · Rule based · BackgroundBackgroundDiphenhydramineIntervention entry›As of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Lymphoma

From the registry record0 judgments on this link
RegistryLymphoma, as filedthe registry files the study under it
=as filed
No judgmentUnchangedshown as the registry files it

All judgments on this study

WhenLinkJudgeDecisionState
Nov 12The record itselfClinicalTrials.gov recordVersion of 2026-11-12Record change
As of nowLymphoma, Non-HodgkinRule based · main-condition ruleMain conditionCurrent
As of nowObinutuzumabRule based · role ruleBackgroundCurrent
As of nowPrednisoneRule based · role ruleBackgroundCurrent
As of nowLenalidomideRule based · role ruleBackgroundCurrent
As of nowPolatuzumabRule based · role ruleTestedCurrent
As of nowPolatuzumabRule based · role ruleTestedCurrent
As of nowIbrutinibRule based · role ruleBackgroundCurrent
As of nowVenetoclaxRule based · role ruleBackgroundCurrent
As of nowVenetoclaxRule based · role ruleBackgroundCurrent
As of nowAcetaminophenRule based · role ruleBackgroundCurrent
As of nowDiphenhydramineRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.